| |
 |
ARTICLES 
|
|
| Inherited breast cancer: increasingly familiar territory |
| J Garber |
|
JCO May 1 1998: 1639–1641.
[PDF]
|
 |
|
BRCA-associated breast cancer in young women |
| |
M Robson, T Gilewski, B Haas, D Levin, P Borgen, P Rajan, Y Hirschaut, P Pressman, PP Rosen, ML Lesser, L Norton, and K Offit |
| |
JCO May 1 1998: 1642–1649.
[Abstract]
[PDF]
|
|
|
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing |
| |
C Lerman, C Hughes, SJ Lemon, D Main, C Snyder, C Durham, S Narod, and HT Lynch |
| |
JCO May 1 1998: 1650–1654.
[Abstract]
[PDF]
|
|
|
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy |
| |
SG Diab, SG Hilsenbeck, C de Moor, GM Clark, CK Osborne, PM Ravdin, and RM Elledge |
| |
JCO May 1 1998: 1655–1660.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer |
| |
PJ Cagnoni, Y Nieto, EJ Shpall, SI Bearman, AE Baron, M Ross, S Matthes, SE Dunbar, and RB Jones |
| |
JCO May 1 1998: 1661–1668.
[Abstract]
[PDF]
|
|
|
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment |
| |
G Falkson, RS Gelman, KJ Pandya, CK Osborne, D Tormey, FJ Cummings, GW Sledge, and MD Abeloff |
| |
JCO May 1 1998: 1669–1676.
[Abstract]
[PDF]
|
|
|
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer |
| |
A Ciarmiello, S Del Vecchio, P Silvestro, MI Potena, MV Carriero, R Thomas, G Botti, G D'Aiuto, and M Salvatore |
| |
JCO May 1 1998: 1677–1683.
[Abstract]
[PDF]
|
|
|
Vascular enumeration as a significant prognosticator for invasive breast carcinoma |
| |
MJ Acenero, JF Gonzalez, MG Gallego, and PA Ballesteros |
| |
JCO May 1 1998: 1684–1688.
[Abstract]
[PDF]
|
|
|
Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer |
| |
JA Broeckel, PB Jacobsen, J Horton, L Balducci, and GH Lyman |
| |
JCO May 1 1998: 1689–1696.
[Abstract]
[PDF]
|
|
|
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma |
| |
F Boulad, NA Kernan, MP LaQuaglia, G Heller, KL Lindsley, NS Rosenfield, SJ Abramson, WL Gerald, TN Small, AP Gillio, SC Gulati, RJ O'Reilly, and F Ghavimi |
| |
JCO May 1 1998: 1697–1706.
[Abstract]
[PDF]
|
|
|
Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Societe Francaise d'Oncologie Pediatrique |
| |
C Fagnou, J Michon, M Peter, A Bernoux, O Oberlin, JM Zucker, H Magdelenat, and O Delattre |
| |
JCO May 1 1998: 1707–1711.
[Abstract]
[PDF]
|
|
|
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study |
| |
DH Mahoney, Jr, JJ Shuster, R Nitschke, SJ Lauer, CP Steuber, N Winick, and B Camitta |
| |
JCO May 1 1998: 1712–1722.
[Abstract]
[PDF]
|
|
|
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study |
| |
RK Mulhern, JL Kepner, PR Thomas, FD Armstrong, HS Friedman, and LE Kun |
| |
JCO May 1 1998: 1723–1728.
[Abstract]
[PDF]
|
|
|
Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute |
| |
MO Granovsky, BU Mueller, HS Nicholson, PS Rosenberg, and CS Rabkin |
| |
JCO May 1 1998: 1729–1735.
[Abstract]
[PDF]
|
|
|
Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study |
| |
FA Shepherd, R Beaulieu, K Gelmon, CA Thuot, C Sawka, S Read, and J Singer |
| |
JCO May 1 1998: 1736–1742.
[Abstract]
[PDF]
|
|
|
Phase III trial of dacarbazine versus dacarbazine with interferon alpha- 2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study |
| |
CI Falkson, J Ibrahim, JM Kirkwood, AS Coates, MB Atkins, and RH Blum |
| |
JCO May 1 1998: 1743–1751.
[Abstract]
[PDF]
|
|
|
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma |
| |
SS Legha, S Ring, O Eton, A Bedikian, AC Buzaid, C Plager, and N Papadopoulos |
| |
JCO May 1 1998: 1752–1759.
[Abstract]
[PDF]
|
|
|
Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma |
| |
BJ Curry, K Myers, and P Hersey |
| |
JCO May 1 1998: 1760–1769.
[Abstract]
[PDF]
|
|
|
Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma |
| |
DJ Macfarlane, V Sondak, T Johnson, and RL Wahl |
| |
JCO May 1 1998: 1770–1776.
[Abstract]
[PDF]
|
|
|
Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies [published erratum appears in J Clin Oncol 1998 Jul;16(7):2575] |
| |
AN Serafini, JL Klein, BG Wolff, R Baum, A Chetanneau, A Pecking, AJ Fischman, HC Hoover, Jr, GE Wynant, R Subramanian, DK Goroff, and MG Hanna, Jr |
| |
JCO May 1 1998: 1777–1787.
[Abstract]
[PDF]
|
|
|
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial |
| |
G Riethmuller, E Holz, G Schlimok, W Schmiegel, R Raab, K Hoffken, R Gruber, I Funke, H Pichlmaier, H Hirche, P Buggisch, J Witte, and R Pichlmayr |
| |
JCO May 1 1998: 1788–1794.
[Abstract]
[PDF]
|
|
|
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine |
| |
DR Budman, NJ Meropol, B Reigner, PJ Creaven, SM Lichtman, E Berghorn, J Behr, RJ Gordon, B Osterwalder, and T Griffin |
| |
JCO May 1 1998: 1795–1802.
[Abstract]
[PDF]
|
|
|
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings |
| |
ME Dolan, SK Roy, AA Fasanmade, PR Paras, RL Schilsky, and MJ Ratain |
| |
JCO May 1 1998: 1803–1810.
[Abstract]
[PDF]
|
|
|
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264 |
| |
AP Venook, MJ Egorin, GL Rosner, TD Brown, TM Jahan, G Batist, R Hohl, D Budman, MJ Ratain, CM Kearns, and RL Schilsky |
| |
JCO May 1 1998: 1811–1819.
[Abstract]
[PDF]
|
|
|
Multicenter phase II trial of interleukin-2, interferon-alpha, and 13- cis-retinoic acid in patients with metastatic renal-cell carcinoma |
| |
WM Stadler, T Kuzel, M Dumas, and NJ Vogelzang |
| |
JCO May 1 1998: 1820–1825.
[Abstract]
[PDF]
|
|
|
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus |
| |
DH Ilson, J Ajani, K Bhalla, A Forastiere, Y Huang, P Patel, L Martin, J Donegan, R Pazdur, C Reed, and DP Kelsen |
| |
JCO May 1 1998: 1826–1834.
[Abstract]
[PDF]
|
|
|
Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer |
| |
DC Smith, RL Dunn, MS Strawderman, and KJ Pienta |
| |
JCO May 1 1998: 1835–1843.
[Abstract]
[PDF]
|
|
|
Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma |
| |
BG Redman, DC Smith, L Flaherty, W Du, and M Hussain |
| |
JCO May 1 1998: 1844–1848.
[Abstract]
[PDF]
|
|
|
Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens |
| |
M Markman, PG Rose, E Jones, IR Horowitz, A Kennedy, K Webster, J Belinson, N Fusco, L Fluellen, B Kulp, G Peterson, and WP McGuire |
| |
JCO May 1 1998: 1849–1851.
[Abstract]
[PDF]
|
|
|
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer |
| |
C Aghajanian, D Fennelly, F Shapiro, R Waltzman, L Almadrones, C O'Flaherty, K O'Conner, E Venkatraman, R Barakat, J Curtin, C Brown, L Reich, D Wuest, L Norton, W Hoskins, and DR Spriggs |
| |
JCO May 1 1998: 1852–1860.
[Abstract]
[PDF]
|
|
|
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer |
| |
AG Zeimet, M Widschwendter, C Knabbe, D Fuchs, M Herold, E Muller-Holzner, G Daxenbichler, FA Offner, O Dapunt, and C Marth |
| |
JCO May 1 1998: 1861–1868.
[Abstract]
[PDF]
|
|
|
Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma |
| |
Y Shimizu, F Akiyama, S Umezawa, T Ishiya, K Utsugi, and K Hasumi |
| |
JCO May 1 1998: 1869–1878.
[Abstract]
[PDF]
|
|
|
Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design |
| |
KR Brader, M Morris, C Levenback, L Levy, KR Lucas, and DM Gershenson |
| |
JCO May 1 1998: 1879–1884.
[Abstract]
[PDF]
|
|
|
Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia |
| |
RB Weiss, J Freiman, SL Kweder, LF Diehl, and JC Byrd |
| |
JCO May 1 1998: 1885–1889.
[Abstract]
[PDF]
|
|
|
Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? |
| |
M Dissing, MM Le Beau, and J Pedersen-Bjergaard |
| |
JCO May 1 1998: 1890–1896.
[Abstract]
[PDF]
|
|
| Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors |
| J Pedersen-Bjergaard, MK Andersen, and B Johansson |
|
JCO May 1 1998: 1897–1898.
[PDF]
|
|
|
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor |
| |
RL Basser, LB To, CG Begley, D Maher, C Juttner, J Cebon, R Mansfield, I Olver, G Duggan, J Szer, J Collins, B Schwartz, J Marty, D Menchaca, WP Sheridan, RM Fox, and MD Green |
| |
JCO May 1 1998: 1899–1908.
[Abstract]
[PDF]
|
|
|
Emerging role of laparoscopy in the diagnosis of lymphoma |
| |
GB Mann, KC Conlon, M LaQuaglia, E Dougherty, CH Moskowitz, and AD Zelenetz |
| |
JCO May 1 1998: 1909–1915.
[Abstract]
[PDF]
|
|
|
Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone |
| |
NR Schechter, CS Portlock, and J Yahalom |
| |
JCO May 1 1998: 1916–1921.
[Abstract]
[PDF]
|
|
|
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group |
| |
W Hiddemann, M Unterhalt, R Herrmann, HH Woltjen, ED Kreuser, L Trumper, M Reuss-Borst, E Terhardt-Kasten, M Busch, A Neubauer, U Kaiser, RD Hanrath, H Middeke, G Helm, M Freund, H Stein, M Tiemann, and R Parwaresch |
| |
JCO May 1 1998: 1922–1930.
[Abstract]
[PDF]
|
|
|
Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins |
| |
E Sanchez, I Chacon, MM Plaza, E Munoz, MA Cruz, B Martinez, L Lopez, JC Martinez- Montero, JL Orradre, AI Saez, JF Garcia, and MA Piris |
| |
JCO May 1 1998: 1931–1939.
[Abstract]
[PDF]
|
|
|
New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen |
| |
V Westeel, N Murray, K Gelmon, A Shah, F Sheehan, M McKenzie, F Wong, J Morris, C Grafton, V Tsang, K Goddard, K Murphy, C Parsons, R Amy, and R Page |
| |
JCO May 1 1998: 1940–1947.
[Abstract]
[PDF]
|
|
|
Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer |
| |
J Zalcberg, M Millward, J Bishop, M McKeage, A Zimet, G Toner, M Friedlander, C Barter, D Rischin, C Loret, R James, N Bougan, and J Berille |
| |
JCO May 1 1998: 1948–1953.
[Abstract]
[PDF]
|
|
|
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B |
| |
TA Ahles, PM Silberfarb, J Herndon, 2nd, LH Maurer, AB Kornblith, J Aisner, MC Perry, WL Eaton, LL Zacharski, MR Green, and JC Holland |
| |
JCO May 1 1998: 1954–1960.
[Abstract]
[PDF]
|
|
|
Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom |
| |
L Fallowfield, M Lipkin, and A Hall |
| |
JCO May 1 1998: 1961–1968.
[Abstract]
[PDF]
|
|
|
BRCA1 and BRCA2: from molecular genetics to clinical medicine |
| |
MA Blackwood and BL Weber |
| |
JCO May 1 1998: 1969–1977.
[Abstract]
[PDF]
|
|
|
Pregnancy after bone marrow transplantation |
| |
SC Gulati and C Van Poznak |
| |
JCO May 1 1998: 1978–1985.
[Abstract]
[PDF]
|
|
|
Cancer care during the last phase of life |
| |
|
| |
JCO May 1 1998: 1986–1996.
[Abstract]
[PDF]
|
|
| Diagnosis in oncology. Askin tumor |
| JF Amatruda, K Tran, M Mantel, S Singer, and G Demetri |
|
JCO May 1 1998: 1997–1998.
[PDF]
|
|
| Radiation therapy for stage II seminoma |
| EW Winquist |
|
JCO May 1 1998: 1999a.
[PDF]
|
|
| Differences in toxicity findings for antiestrogens |
| GM Williams |
|
JCO May 1 1998: 1999b–2000.
[PDF]
|
|
